111 Inc
NASDAQ:YI
111 Inc
Revenue
111 Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Revenue
¥14.9B
|
CAGR 3-Years
22%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Revenue
¥24.2B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Revenue
¥22.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Revenue
¥7.5B
|
CAGR 3-Years
29%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Revenue
¥22.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Revenue
¥18.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Revenue?
Revenue
14.9B
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Revenue amounts to 14.9B CNY.
What is 111 Inc's Revenue growth rate?
Revenue CAGR 5Y
53%
Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for 111 Inc have been 22% over the past three years , 53% over the past five years .